|
The inspection was conducted between 6 April 2022 and 12 April 2022 in Baddi, Daman facility.
At the end of the inspection, no observations critical to Good Manufacturing Practices (GMP) were detected by Instituto de Salud Pública de Chile (ISP Chile), the Chilean Public Health Institute.
Alkem Laboratories is engaged in pharmaceutical business with global operations. The Company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products.
On consolidated basis, the pharma company reported 15% increase in net profit to Rs 533.35 crore on 13% increase in net sales to Rs 2618.98 crore in Q3 FY22 over Q3 FY21.
Shares of Alkem Laboratories were trading 0.27% lower at Rs 3442.20 on BSE.
|